Bradley Pharmaceuticals, Inc. (NYSE: BDY) announced the launch of Elestrin by the Company's Kenwood Therapeutics Division ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE